Annual report [Section 13 and 15(d), not S-K Item 405]

Business (Details Narrative)

v3.25.0.1
Business (Details Narrative)
12 Months Ended
Dec. 31, 2024
USD ($)
Integer
Dec. 31, 2023
USD ($)
Patents owned by the company 106  
Expired patents 54  
Foreign patents owned by the company 16  
ILiAD Biotechnologies LLC [Member]    
Aggregate investment amount | $ $ 7,000,000 $ 7,000,000